Advertisement

Topics

ImmusanT closes $40mm Series C

14:40 EST 14 Nov 2017 | Elsevier Business Intelligence

GI-focused ImmusanT Inc. raised $40mm in its Series C financing led by Arch Venture Partners, which adds a board member and w...

Original Article: ImmusanT closes $40mm Series C

NEXT ARTICLE

More From BioPortfolio on "ImmusanT closes $40mm Series C"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...